There was a significant increase in myelin basic proteins at all ages for rats that received 0.3 mg/kg/day of buprenorphine. For those treated with 1 mg/kg/day of buprenorphine, there was a significant decrease in rats at 12 days and there was no significant difference at 19 and 26 days of age. There was also no differences in MBP levels between the different isoforms, indicated that they are affected the same.
The increase of MBPs at the lower dosage across all age groups, coupled with the significant decrease at the higher dosage for the 12 day old group suggests a dose-specific response.
Because there was only a decrease at the higher dosage for 12 day old rats, it indicates that myelination is delayed, but not prevented since the 19 and 26 day age group reaches levels that are similar to the control.